Biotage Turbo Vaps

The Food and Drug Administration is preparing to replace its aging Biotage Turbo Vaps equipment, which has been in use for nearly two decades and is now experiencing critical mechanical failures, particularly with adjusting valves. Support for these outdated units is no longer available, making replacement essential to maintain operational efficiency and reliability in laboratory processes. The anticipated procurement is forecasted with a NAICS code of 334516, indicating the focus on laboratory equipment manufacturing, and the acquisition will be managed under the agency’s procurement framework without a specified set-aside classification. The point of contact for program inquiries is the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the contracting officer position is currently undetermined. The place of performance and specific delivery location have not been defined, and the opportunity is posted as a forecast on the HHS OSDBU portal with no solicitation number assigned yet.